Kelly C Wade1, Maxwell Pistilli2, Agnieshka Baumritter3, Karen Karp3, Alice Gong4, Alex R Kemper5, Gui-Shuang Ying2, Graham Quinn6. 1. Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. Electronic address: Kelly.wade@uphs.upenn.edu. 2. Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA. 3. Division of Pediatric Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA. 4. Department of Pediatrics, University of Texas, San Antonio, TX. 5. Duke Clinical Research Institute, Durham, NC. 6. Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA; Division of Pediatric Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, PA.
Abstract
OBJECTIVES: To describe adverse events (AEs) and noteworthy clinical or ocular findings associated with retinopathy of prematurity (ROP) evaluation procedures. STUDY DESIGN: Descriptive analysis of predefined AEs and noteworthy findings reported in a prospective observational cohort study of infants <1251 g birth weight who had ROP study visits consisting of both binocular indirect ophthalmoscopy (BIO) and digital retinal imaging. We compared infant characteristics during ROP visits with and without AEs. We compared respiratory support, nutrition, and number of apnea, bradycardia, or hypoxia events 12 hours before and after ROP visits. RESULTS: A total of 1257 infants, mean birth weight 802 g, had 4263 BIO and 4048 imaging sessions (total 8311 procedures). No serious AEs were related to ROP visits. Sixty-five AEs were reported among 61 infants for an AE rate of 4.9% infants (61/1257) or 0.8% total procedures (65/8311 BIO + imaging). Most AEs were due to apnea, bradycardia, and/or hypoxia (68%), tachycardia (16%), or emesis (8%). At ROP visit, infants with AEs, compared with those without, were more likely to be on mechanical ventilation (26% vs 12%, P = .04) even after adjustment for weight and postmenstrual age. Noteworthy clinical findings were reported during 8% BIO and 15% imaging examinations. Respiratory and nutrition support were not significantly different before and after ROP evaluations. CONCLUSIONS: Retinal imaging by nonphysicians combined with BIO was safe. Noteworthy clinical findings occurred during both procedures. Ventilator support was a risk factor for AEs. Monitoring rates of AEs and noteworthy findings are important to the safe implementation of ROP imaging protocols. TRIAL REGISTRATION: Clinicaltrials.gov: NCT01264276.
OBJECTIVES: To describe adverse events (AEs) and noteworthy clinical or ocular findings associated with retinopathy of prematurity (ROP) evaluation procedures. STUDY DESIGN: Descriptive analysis of predefined AEs and noteworthy findings reported in a prospective observational cohort study of infants <1251 g birth weight who had ROP study visits consisting of both binocular indirect ophthalmoscopy (BIO) and digital retinal imaging. We compared infant characteristics during ROP visits with and without AEs. We compared respiratory support, nutrition, and number of apnea, bradycardia, or hypoxia events 12 hours before and after ROP visits. RESULTS: A total of 1257 infants, mean birth weight 802 g, had 4263 BIO and 4048 imaging sessions (total 8311 procedures). No serious AEs were related to ROP visits. Sixty-five AEs were reported among 61 infants for an AE rate of 4.9% infants (61/1257) or 0.8% total procedures (65/8311 BIO + imaging). Most AEs were due to apnea, bradycardia, and/or hypoxia (68%), tachycardia (16%), or emesis (8%). At ROP visit, infants with AEs, compared with those without, were more likely to be on mechanical ventilation (26% vs 12%, P = .04) even after adjustment for weight and postmenstrual age. Noteworthy clinical findings were reported during 8% BIO and 15% imaging examinations. Respiratory and nutrition support were not significantly different before and after ROP evaluations. CONCLUSIONS: Retinal imaging by nonphysicians combined with BIO was safe. Noteworthy clinical findings occurred during both procedures. Ventilator support was a risk factor for AEs. Monitoring rates of AEs and noteworthy findings are important to the safe implementation of ROP imaging protocols. TRIAL REGISTRATION: Clinicaltrials.gov: NCT01264276.
Authors: Natalia Fijalkowski; Luo Luo Zheng; Michael T Henderson; Sean K Wang; Matthew B Wallenstein; Theodore Leng; Darius M Moshfeghi Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014-01-20 Impact factor: 1.300
Authors: Graham E Quinn; Gui-shuang Ying; Ebenezer Daniel; P Lloyd Hildebrand; Anna Ells; Agnieshka Baumritter; Alex R Kemper; Eleanor B Schron; Kelly Wade Journal: JAMA Ophthalmol Date: 2014-10 Impact factor: 7.389
Authors: M Teresa Moral-Pumarega; Sonia Caserío-Carbonero; Javier De-La-Cruz-Bértolo; Pilar Tejada-Palacios; David Lora-Pablos; Carmen R Pallás-Alonso Journal: BMC Pediatr Date: 2012-08-28 Impact factor: 2.125
Authors: Hilal Biten; Travis K Redd; Chace Moleta; J Peter Campbell; Susan Ostmo; Karyn Jonas; R V Paul Chan; Michael F Chiang Journal: JAMA Ophthalmol Date: 2018-05-01 Impact factor: 7.389
Authors: Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington Journal: Pediatr Res Date: 2017-08-16 Impact factor: 3.756
Authors: Kelly C Wade; Gui-Shuang Ying; Agnieshka Baumritter; Alice Gong; Alex R Kemper; Graham E Quinn Journal: JAMA Ophthalmol Date: 2019-02-01 Impact factor: 7.389
Authors: Graham E Quinn; Gui-Shuang Ying; Michael X Repka; R Michael Siatkowski; Robert Hoffman; Monte D Mills; David Morrison; Ebenezer Daniel; Agnieshka Baumritter; P Lloyd Hildebrand; Eleanor B Schron; Anna L Ells; Kelly Wade; Alex R Kemper Journal: J AAPOS Date: 2016-09-17 Impact factor: 1.220
Authors: Mark B Horton; Christopher J Brady; Jerry Cavallerano; Michael Abramoff; Gail Barker; Michael F Chiang; Charlene H Crockett; Seema Garg; Peter Karth; Yao Liu; Clark D Newman; Siddarth Rathi; Veeral Sheth; Paolo Silva; Kristen Stebbins; Ingrid Zimmer-Galler Journal: Telemed J E Health Date: 2020-03-25 Impact factor: 3.536
Authors: Graham E Quinn; Anna Ells; Antonio Capone; G Baker Hubbard; Ebenezer Daniel; P Lloyd Hildebrand; Gui-Shuang Ying Journal: JAMA Ophthalmol Date: 2016-11-01 Impact factor: 7.389